Royalty Pharma PLC (RPRX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

110 EAST 59TH STREET NEW YORK, NY 10022

Royalty Pharma plc acquires biopharmaceutical royalties. The Company funds innovation directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators.

Data as of 2021-04-17 11:27:50 -0400
Market Cap16.251 Billion Shares Outstanding388.132 Million Avg 30-day Volume3.303 Million
P/E Ratio0.0 Dividend Yield1.119 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE15.89 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low55.87 / 34.55 Next Earnings Date2021-05-12 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from RPRX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 10 6 66.67% 4 (0.24%) 2 (0.12%) 100.0%
Funds Holding: 192 131 46.56% 54 (3.25%) 45 (2.8%) 20.0%
13F shares: 229.785 Million 158.558 Million 44.92% 96.484 Million 75.553 Million 27.7%
% Ownership
New Positions: 90 49 83.67% 23 12 91.67%
Increased Positions 68 47 44.68% 22 16 37.5%
Closed Positions 26 39 -33.33% 13 20 -35.0%
Reduced Positions 23 16 43.75% 8 7 14.29%
Total Calls 350.449 Thousand 111.077 Thousand 215.5% 82.8 Thousand 24.7 Thousand 235.22%
Total Puts 774.54 Thousand 147.857 Thousand 423.84% 593.5 Thousand 21.9 Thousand 2610.05%
PUT/CALL Ratio 2.21 1.33 66.17% 7.17 0.89 705.62%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RPRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RPRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

25.7 Thousand total shares from 1 transactions

Open Market Sells (S)

682 Thousand total shares from 23 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LLOYD GEORGE W. EVP, INVESTMENTS & GC

  • Officer
526,960 2021-04-14 5

REDDOCH JAMES F. EVP, RESEARCH & INVESTMENTS

  • Officer
225,030 2021-04-14 5

FERNANDEZ HENRY A

  • Director
35,229 2021-03-31 6

BASSLER BONNIE L

  • Director
15,183 2021-03-31 4

HITE CHRISTOPHER EVP & VICE CHAIRMAN

  • Officer
30,541 2021-03-23 1

COYNE TERRANCE P. EVP & CFO

  • Officer
250,390 2021-03-03 5

URIST MARSHALL EVP & CO-HEAD RESEARCH & INV.

  • Officer
19,020 2020-12-21 1

ADAGE CAPITAL PARTNERS GP, L.L.C.

ADAGE CAPITAL PARTNERS, L.P.

ADAGE CAPITAL ADVISORS, L.L.C.

ATCHINSON ROBERT

GROSS PHILLIP

  • 10% Owner
38,714,280 2020-12-17 1

RIGGS RORY B

  • Director
15,000 2020-10-20 3

FORD WILLIAM E

  • Director
4,689,750 2020-10-20 1

ENGELBERT CATHERINE M.

  • Director
13,410 2020-09-30 2

LOVE TED W

  • Director
17,280 2020-08-13 2

NORDEN GREGORY

  • Director
44,644 2020-06-15 1

DESOUZA ERROL B

  • Director
44,644 2020-06-15 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LLOYD GEORGE W. - Officer EVP, INVESTMENTS & GC by gwl 2013 ng, llc

2021-04-16 17:57:01 -0400 2021-04-14 S 13,924 $42.12 d 50,000 indirect -0.79 0.0 1 -0.79 2

REDDOCH JAMES F. - Officer EVP, RESEARCH & INVESTMENTS by reddoch rpi llc

2021-04-16 17:56:26 -0400 2021-04-14 S 55,714 $42.10 d 200,000 indirect -0.79 0.0 1 -0.79 2

LLOYD GEORGE W. - Officer EVP, INVESTMENTS & GC by gwl 2014 g, llc

2021-04-16 17:57:01 -0400 2021-04-14 S 55,898 $42.14 d 200,000 indirect -0.79 0.0 1 -0.79 2

REDDOCH JAMES F. - Officer EVP, RESEARCH & INVESTMENTS by reddoch rpi llc

2021-04-14 07:51:30 -0400 2021-04-12 S 359 $42.32 d 255,714 indirect -1.1159 1.567 1.567 6 -1.6144 5

LLOYD GEORGE W. - Officer EVP, INVESTMENTS & GC by gwl 2014 g, llc

2021-04-14 07:52:45 -0400 2021-04-12 S 360 $42.32 d 255,898 indirect -1.1159 1.567 1.567 6 -1.6144 5

LLOYD GEORGE W. - Officer EVP, INVESTMENTS & GC by gwl 2013 ng, llc

2021-04-14 07:52:45 -0400 2021-04-12 S 89 $42.32 d 63,924 indirect -1.1159 1.567 1.567 6 -1.6144 5

BASSLER BONNIE L - Director

2021-04-02 17:35:21 -0400 2021-03-31 A 816 $45.90 a 15,183 direct -0.445 -3.4426 0.0 1 -3.4426 6

FERNANDEZ HENRY A - Director

2021-04-02 17:30:25 -0400 2021-03-31 A 816 $45.90 a 9,529 direct -0.445 -3.4426 0.0 1 -3.4426 6

HITE CHRISTOPHER - Officer EVP & VICE CHAIRMAN

2021-03-25 19:53:21 -0400 2021-03-23 S 31,959 $469.86 d 30,541 direct

LLOYD GEORGE W. - Officer EVP, INVESTMENTS & GC by gwl 2013 ng, llc

2021-03-24 17:25:11 -0400 2021-03-22 S 10,987 $46.34 d 64,013 indirect -0.1634 0.4203 1.8678 4 -0.1634 2

LLOYD GEORGE W. - Officer EVP, INVESTMENTS & GC by gwl 2014 g, llc

2021-03-24 17:25:11 -0400 2021-03-22 S 100 $47.04 d 256,258 indirect -0.1634 0.4203 1.8678 4 -0.1634 2

REDDOCH JAMES F. - Officer EVP, RESEARCH & INVESTMENTS by reddoch rpi llc

2021-03-24 17:25:18 -0400 2021-03-22 S 43,927 $46.32 d 256,073 indirect -0.1634 0.4203 1.8678 4 -0.1634 2

LLOYD GEORGE W. - Officer EVP, INVESTMENTS & GC by gwl 2014 g, llc

2021-03-24 17:25:11 -0400 2021-03-22 S 43,642 $46.32 d 256,358 indirect -0.1634 0.4203 1.8678 4 -0.1634 2

COYNE TERRANCE P. - Officer EVP & CFO by tpc rp, llc

2021-03-05 19:04:34 -0500 2021-03-03 S 11,001 $45.86 d 201,456 indirect 2.6533 4.437 -7.6031 8.4058 8 -8.0713 25

COYNE TERRANCE P. - Officer EVP & CFO by tpc rp, llc

2021-03-05 19:04:34 -0500 2021-03-03 S 57,723 $45.09 d 212,457 indirect 2.6533 4.437 -7.6031 8.4058 8 -8.0713 25

COYNE TERRANCE P. - Officer EVP & CFO by tpc rp, llc

2021-03-05 19:04:34 -0500 2021-03-03 S 1,456 $46.83 d 200,000 indirect 2.6533 4.437 -7.6031 8.4058 8 -8.0713 25

COYNE TERRANCE P. - Officer EVP & CFO by tpc rp, llc

2021-03-05 19:04:34 -0500 2021-03-03 S 29,820 $43.71 d 270,180 indirect 2.6533 4.437 -7.6031 8.4058 8 -8.0713 25

LLOYD GEORGE W. - Officer EVP, INVESTMENTS & GC by gwl 2014 g, llc

2021-03-04 19:03:50 -0500 2021-03-02 S 3,510 $47.85 d 300,000 indirect 5.4302 10.2962 -1.8101 14.2924 9 -3.0795 26

LLOYD GEORGE W. - Officer EVP, INVESTMENTS & GC by gwl 2013 ng, llc

2021-03-04 19:03:50 -0500 2021-03-02 S 22,375 $46.89 d 77,625 indirect 5.4302 10.2962 -1.8101 14.2924 9 -3.0795 26

COYNE TERRANCE P. - Officer EVP & CFO by tpc rp, llc

2021-03-04 19:00:51 -0500 2021-03-02 S 5,022 $47.88 d 300,000 indirect 5.4302 10.2962 -1.8101 14.2924 9 -3.0795 26

LLOYD GEORGE W. - Officer EVP, INVESTMENTS & GC by gwl 2014 g, llc

2021-03-04 19:03:50 -0500 2021-03-02 S 96,490 $46.89 d 303,510 indirect 5.4302 10.2962 -1.8101 14.2924 9 -3.0795 26

REDDOCH JAMES F. - Officer EVP, RESEARCH & INVESTMENTS by reddoch rpi llc

2021-03-04 19:02:13 -0500 2021-03-02 S 3,510 $47.84 d 300,000 indirect 5.4302 10.2962 -1.8101 14.2924 9 -3.0795 26

COYNE TERRANCE P. - Officer EVP & CFO by tpc rp, llc

2021-03-04 19:00:51 -0500 2021-03-02 S 94,978 $46.89 d 305,022 indirect 5.4302 10.2962 -1.8101 14.2924 9 -3.0795 26

LLOYD GEORGE W. - Officer EVP, INVESTMENTS & GC by gwl 2013 ng, llc

2021-03-04 19:03:50 -0500 2021-03-02 S 2,625 $47.84 d 75,000 indirect 5.4302 10.2962 -1.8101 14.2924 9 -3.0795 26

REDDOCH JAMES F. - Officer EVP, RESEARCH & INVESTMENTS by reddoch rpi llc

2021-03-04 19:02:13 -0500 2021-03-02 S 96,490 $46.89 d 303,510 indirect 5.4302 10.2962 -1.8101 14.2924 9 -3.0795 26

FERNANDEZ HENRY A - Director by fernandez 2007 children's trust

2021-02-26 19:46:56 -0500 2021-02-25 P 25,700 $46.83 a 25,700 indirect -2.2486 -6.6209 -13.7414 1.2284 13 -14.1578 30

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ROYALTY PHARMA PLC- CL A RPRX 2021-04-23 14:45:03 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-23 14:15:03 UTC -0.19 0.25 1500000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-23 13:45:03 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-23 13:15:03 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-23 12:45:02 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 22:15:03 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 21:45:04 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 21:15:03 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 20:45:03 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 20:15:03 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 19:45:02 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 19:15:03 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 18:45:02 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 18:15:03 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 17:45:02 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 17:15:03 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 16:45:03 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 16:15:02 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 15:45:03 UTC -0.19 0.25 1400000
ROYALTY PHARMA PLC- CL A RPRX 2021-04-22 15:15:03 UTC -0.19 0.25 1400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RBB Fund, Inc.- Boston Partners Long/Short Research Fund RPRX -51235.0 shares, $-2182611.0 2020-11-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund RPRX -6300.0 shares, $-315315.0 2020-12-31 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund RPRX -4014.0 shares, $-188698.14 2021-01-31 N-PORT
Series Portfolios Trust- Weiss Alternative Balanced Risk Fund RPRX -147.0 shares, $-6910.47 2021-01-31 N-PORT

Elevate your investments